Back to search

Sweden· SE-20140108000060

Spectrila 10 000 E Pulver till injektions-/infusionsvätska, lösning

A medicinal product containing asparaginase, registered in Sweden by medac Gesellschaft für klinische Spezialpräparate mbH.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedSpectrila 10 000 E Pulver till injekt…ATC—REGISTER NO.SE-20140108000060PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Asparaginase
Manufacturer
medac Gesellschaft für klinische Spezialpräparate mbH
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20140108000060

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Asparaginase in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All asparaginase products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Enrylaze, Spectrila
  • Liechtenstein · Enrylaze, Spectrila
  • Norway · Enrylaze, Spectrila

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee6409f8-3d04-4411-bab0-c97740925bd0
GET /v1/drugs/ee6409f8-3d04-4411-bab0-c97740925bd0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EMA",
    "EPAR"
  ],
  "se_npl_id": "20140108000060",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140108000060",
  "product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/spectrila"
}

See everything about asparaginase.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.